Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Celecoxib + vitamin B is a fixed-dose combination of the nonsteroidal anti-inflammatory drug (NSAID) celecoxib and one or more B vitamins, typically used for the management of chronic low back pain. Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that reduces inflammation and pain by inhibiting prostaglandin synthesis. The addition of B vitamins, often including thiamine (B1), pyridoxine (B6), and cyanocobalamin (B12), is intended to support nerve health and potentially enhance analgesic effects. Clinical studies have shown that this combination can provide greater relief from chronic pain syndromes compared to celecoxib alone, with improved restoration of motor function in patients with nonspecific lumbar pain[2][3]. The combination has been evaluated in phase III clinical trials for chronic low back pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on celecoxib + vitamin b.